Liu Fan, Wen Zehuai, Wei Jia, Xue Huiling, Chen Yunqin, Gao Weiguo, Melnick David, Gonzalez Jesus, Hackett Judith, Li Xiaoyan, Deng Shizhou, Cao Zhaolong
People's Hospital, Peking University, Beijing 100044, China.
Key Unit of Methodology in Clinical Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China.
J Thorac Dis. 2017 Oct;9(10):3875-3887. doi: 10.21037/jtd.2017.09.18.
Data describing epidemiology, clinical outcomes and treatment patterns, of hospitalised patients with pneumonia in China are limited. We aimed to describe such information among adult pneumonia patients in southern and northern China.
We retrospectively reviewed electronic medical records of pneumonia patients aged ≥18 years, hospitalized between 2008 and 2013 at Guangdong Provincial Hospital of Chinese Medicine (n=3,636), southern China, and between 2010 and 2014 at Peking University People's Hospital, Beijing (n=1,689), northern China, in order to collect data on patient demographics, microbiology, clinical outcomes and treatment and resistance patterns.
The mean (SD) age of patients was 60.0 (21.4) and 64.4 (18.4) years in Guangdong and Beijing, respectively. Mean length of hospital stay was 12.1 and 20.8 days, and overall mortality was 2.9% and 8.0%, respectively. Gram-negative bacilli were most frequently isolated, predominantly and . Infection with these bacteria was associated with unfavourable clinical outcomes, and the antibiotic resistance among these bacteria increased between 2008-2010 and 2011-2013 in both regions of China. The treatment and choice of antibiotics slightly varied between the two regions based on the susceptible pathogens identified among their populations.
Of the pathogens identified, infection (particularly the methicillin-resistant S. ) was associated with poor clinical outcomes; however antibiotic resistance among S. generally decreased during the study data collection periods. Also, disease severity was greater in Beijing as compared with Guangdong, and this may be associated with higher microbiological diagnosis rate and higher frequency of initial antibiotic modification among Beijing populations.
关于中国住院肺炎患者的流行病学、临床结局和治疗模式的数据有限。我们旨在描述中国南方和北方成年肺炎患者的此类信息。
我们回顾性分析了2008年至2013年期间在中国南方广东省中医院住院的≥18岁肺炎患者的电子病历(n = 3636),以及2010年至2014年期间在北京北京大学人民医院住院的患者的电子病历(n = 1689),以收集患者人口统计学、微生物学、临床结局以及治疗和耐药模式的数据。
广东和北京患者的平均(标准差)年龄分别为60.0(21.4)岁和64.4(18.4)岁。平均住院时间分别为12.1天和20.8天,总体死亡率分别为2.9%和8.0%。革兰氏阴性杆菌是最常分离出的细菌,主要是 和 。这些细菌感染与不良临床结局相关,并且在中国这两个地区,2008 - 2010年至2011 - 2013年期间这些细菌的抗生素耐药性有所增加。根据两个地区人群中鉴定出的易感病原体,抗生素的治疗和选择略有不同。
在所鉴定的病原体中, 感染(尤其是耐甲氧西林金黄色葡萄球菌)与不良临床结局相关;然而,在研究数据收集期间,金黄色葡萄球菌的抗生素耐药性总体上有所下降。此外,北京的疾病严重程度高于广东,这可能与北京人群中较高的微生物学诊断率和初始抗生素调整频率有关。